Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.1%

9 terminated/withdrawn out of 218 trials

Success Rate

90.9%

+4.3% vs industry average

Late-Stage Pipeline

8%

18 trials in Phase 3/4

Results Transparency

8%

7 of 90 completed trials have results

Key Signals

32 recruiting7 with results8 terminated

Enrollment Performance

Analytics

N/A
80(58.4%)
Phase 2
28(20.4%)
Phase 3
12(8.8%)
Phase 1
9(6.6%)
Phase 4
6(4.4%)
Early Phase 1
2(1.5%)
137Total
N/A(80)
Phase 2(28)
Phase 3(12)
Phase 1(9)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (218)

Showing 20 of 218 trials
NCT05880160Not ApplicableCompleted

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction

Role: collaborator

NCT05197322Phase 2Active Not Recruiting

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Role: collaborator

NCT07808528Not ApplicableNot Yet Recruiting

Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre Scanner Calibration) and Validation Component (Multi-centre Validation)

Role: collaborator

NCT06607783Recruiting

PRostate Cancer Enhanced Diagnosis by Calibration Technology

Role: collaborator

NCT07422935Not ApplicableRecruiting

Plant-Protein Dominant Tube Feed Study

Role: collaborator

NCT07449143Recruiting

Physical Activity Intervention for MPS

Role: collaborator

NCT05777499Not ApplicableCompleted

MUSic Therapy In Complex Specialist Neurorehabilitation

Role: collaborator

NCT07549893Not ApplicableRecruiting

Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural Haematoma (BURR-MMA)

Role: collaborator

NCT07725926Not ApplicableRecruiting

Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)

Role: lead

NCT07717632Not ApplicableActive Not Recruiting

AI-enhanced LF-MRI in Epilepsy

Role: collaborator

NCT05579496Recruiting

Rebooting Infant Pain Care: Using Machine Learning and Skin-to-Skin Contact to Exponentially Improve Neonatal Intensive Care Unit Practice

Role: collaborator

NCT06183437Phase 4Recruiting

The STOP-MED CTRCD Trial

Role: collaborator

NCT04851470Recruiting

Periodontal Assessment of a Bariatric Care Population

Role: collaborator

NCT05088213Not ApplicableCompleted

Suction Mini-PCNL Versus Standard PCNL for the Management of 2-4cm Kidney Stones

Role: collaborator

NCT05537220Phase 3Active Not Recruiting

Oral N-acetylcysteine for Retinitis Pigmentosa

Role: collaborator

NCT03981575Recruiting

Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Role: collaborator

NCT04844775Phase 1Completed

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Role: collaborator

NCT03050931Active Not Recruiting

Electrical Impedance Tomography of Epilepsy

Role: collaborator

NCT06895746Active Not Recruiting

Multi-omics Study in Citrin Deficiency

Role: collaborator

NCT03684564Phase 2Completed

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

Role: collaborator